Singapore vs Switzerland: Estimated antiretroviral therapy coverage among people living with HIV
Singapore
89.0%
in 2024
Switzerland
89.0%
in 2024
Singapore rank
22nd
Switzerland rank
22nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Singapore
- Switzerland
How they compare
Singapore currently reports 89.0% against 89.0% in Switzerland, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Switzerland ahead.
Singapore ranks 22nd and Switzerland ranks 22nd of 143 countries.
Switzerland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.5% | 52.9% | 32.4% | Switzerland |
| 2010s | 74.8% | 78.9% | 4.1% | Switzerland |
| 2020s | 87.8% | 89.0% | 1.2% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Singapore or Switzerland?
- Singapore, at 89.0% against 89.0% in Switzerland as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Singapore and Switzerland?
- 0.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and Switzerland?
- 25 years are reported by both, from 2000 to 2024.
- How do Singapore and Switzerland rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Singapore ranks 22nd and Switzerland ranks 22nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.